{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Massachusetts Expands Oversight of Private Equity Investment in Healthcare: Key Takeaways from House Bill 5159 Signed into Law by Governor Healey",
    "url": "https://www.lexblog.com/2025/01/27/massachusetts-expands-oversight-of-private-equity-investment-in-healthcare-key-takeaways-from-house-bill-5159-signed-into-law-by-governor-healey-2/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-ZC71FR5C",
        "url": "https://www.lexblog.com/lib/ZC71FR5C/"
    },
    "datePublished": "2025-01-27T12:21:27-05:00",
    "dateModified": "2025-01-27T09:22:10-05:00",
    "author": {
        "@type": "Person",
        "name": "Jordan Grushkin, Leonard Lipsky, Daniel Shemano"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Sheppard, Mullin, Richter & Hampton LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Antitrust Law Blog",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.antitrustlawblog.com/?p=5051",
    "sourceStability": "may-move"
}